Targeting the trypanosome kinetochore with CLK1 protein kinase inhibitors
Preprint
Abstract
The kinetochore is a macromolecular structure that assembles on the centromeres of chromosomes and provides the major attachment point for spindle microtubules during mitosis. In Trypanosoma brucei the proteins that make up the kinetochore are highly divergent, with the inner kinetochore comprising at least 20 distinct and essential proteins (KKT1-20) that include four protein kinases, CLK1 (KKT10), CLK2 (KKT19), KKT2 and KKT3. We performed a phenotypic screen of T. brucei bloodstream forms with a Novartis kinase-focused inhibitor library, which identified a number of selective inhibitors with potent pan-kinetoplastid activity. Deconvolution of an amidobenzimidazole series using a selection of 37 T. brucei mutants that over-express known essential protein kinases identified CLK1 as the primary target. Biochemical studies show that the irreversible competitive inhibition of CLK1 is dependent on a Michael acceptor forming an irreversible bond with C215 in the ATP binding pocket, a residue that is not present in human CLK1, thereby providing selectivity. Chemical inhibition of CLK1 impairs inner kinetochore recruitment and compromises cell cycle progression, leading to cell death. We show that KKT2 is a substrate for CLK1 and identify phosphorylation of S508 to be essential for KKT2 function and for kinetochore assembly. We propose that CLK1 is part of a novel signalling cascade that controls kinetochore function via phosphorylation of the inner kinetochore protein kinase KKT2. This work highlights a novel drug target for trypanosomatid parasitic protozoa and a new chemical tool for investigating the function of their divergent kinetochores.Keywords
All Related Versions
- Published version: Nature Microbiology, 5 (10), 1207.
This publication has 49 references indexed in Scilit:
- Highly Sensitive In Vivo Imaging of Trypanosoma brucei Expressing “Red-Shifted” LuciferasePLOS Neglected Tropical Diseases, 2013
- In Vivo Imaging of Trypanosome-Brain Interactions and Development of a Rapid Screening Test for Drugs against CNS Stage TrypanosomiasisPLOS Neglected Tropical Diseases, 2013
- Correction: Hypothemycin, a fungal natural product, identifies therapeutic targets in Trypanosoma bruceieLife, 2013
- Antitrypanosomal Activity of Fexinidazole, a New Oral Nitroimidazole Drug Candidate for Treatment of Sleeping SicknessAntimicrobial Agents and Chemotherapy, 2011
- Cell-cycle synchronisation of bloodstream forms of Trypanosoma brucei using Vybrant DyeCycle Violet-based sortingMolecular and Biochemical Parasitology, 2010
- TriTrypDB: a functional genomic resource for the TrypanosomatidaeNucleic Acids Research, 2009
- The Phosphoproteome of Bloodstream Form Trypanosoma brucei, Causative Agent of African Sleeping SicknessMolecular & Cellular Proteomics, 2009
- The cell cycle as a therapeutic target against Trypanosoma brucei: Hesperadin inhibits Aurora kinase‐1 and blocks mitotic progression in bloodstream formsMolecular Microbiology, 2009
- Identification of a Novel Chromosomal Passenger Complex and Its Unique Localization during Cytokinesis in Trypanosoma bruceiPLOS ONE, 2008
- An Aurora Kinase Homologue Is Involved in Regulating Both Mitosis and Cytokinesis in Trypanosoma bruceiJournal of Biological Chemistry, 2006